Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
- 1 December 2007
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 100 (11), 1659-1664
- https://doi.org/10.1016/j.amjcard.2007.09.072
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward ConsensusJournal of the American College of Cardiology, 2007
- Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in WomenJama-Journal Of The American Medical Association, 2007
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Effect of Statin Therapy on C-Reactive Protein LevelsJama-Journal Of The American Medical Association, 2001
- Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein LevelsCirculation, 2001
- Rapid Reduction in C-Reactive Protein With Cerivastatin Among 785 Patients With Primary HypercholesterolemiaCirculation, 2001
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998